- Report
- May 2026
- 50 Pages
Global
From €2356EUR$2,650USD£2,044GBP
- Report
- May 2026
- 50 Pages
Global
From €2356EUR$2,650USD£2,044GBP
- Report
- May 2026
- 50 Pages
Global
From €2356EUR$2,650USD£2,044GBP
- Report
- May 2026
- 50 Pages
Global
From €2356EUR$2,650USD£2,044GBP
- Report
- May 2026
- 50 Pages
Global
From €2356EUR$2,650USD£2,044GBP
- Report
- May 2026
- 50 Pages
Global
From €2356EUR$2,650USD£2,044GBP
- Report
- December 2025
- 163 Pages
Global
From €4311EUR$4,850USD£3,741GBP
- Report
- October 2025
- 92 Pages
Global
From €4311EUR$4,850USD£3,741GBP
- Report
- September 2025
Global
From €4311EUR$4,850USD£3,741GBP
- Report
- June 2025
- 210 Pages
Global
From €4000EUR$4,500USD£3,471GBP
- Report
- November 2025
- 125 Pages
United States
From €3511EUR$3,950USD£3,047GBP
- Report
- June 2025
- 250 Pages
United States
From €2479EUR$2,789USD£2,152GBP
- Report
- April 2026
- 230 Pages
United States
From €4311EUR$4,850USD£3,741GBP
- Report
- March 2026
- 160 Pages
United States
From €4311EUR$4,850USD£3,741GBP
- Report
- October 2025
- 93 Pages
Middle East
From €4311EUR$4,850USD£3,741GBP
- Report
- October 2025
- 87 Pages
United States
From €4311EUR$4,850USD£3,741GBP
- Report
- September 2024
- 375 Pages
Global
From €4266EUR$4,799USD£3,702GBP
From €450EUR$542USD£404GBP
- Report
- March 2024
- 102 Pages
Global
From €1511EUR$1,700USD£1,311GBP
- Report
- June 2024
- 76 Pages
Global
From €1244EUR$1,400USD£1,080GBP

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more